Showing 7 of 7 recruiting trials for “peripheral-primitive-neuroectodermal-tumor”
A Window of Opportunity Trial of Mirdametinib Plus Vorinostat for NF1 Associated, H3K27 Trimethylation Deficient Malignant Peripheral Nerve Sheath Tumor [MPNST]
GD2-CAR T Cells for Pediatric Brain Tumours
Safety Study of the Repeated Opening of the Blood-brain Barrier With the SonoCloud® Device to Treat Malignant Brain Tumors in Pediatric Patients
👨⚕️ Kevin BECCARIA, MD, PhD, Assistance Publique - Hôpitaux de Paris📍 3 sites📅 Started Feb 2023View details ↗
RecruitingNCT05711992 ↗
Rare Embryonal Tumors of the Central Nervous System: International Registry
👨⚕️ Julieta Hoveyan, MD, Immune Oncology Research Institute, Yerevan, Armenia📍 11 sites📅 Started Feb 2023View details ↗
A Study of ASTX727 in People With Malignant Peripheral Nerve Sheath Tumors (MPNST)
👨⚕️ Ping Chi, MD, PhD, Memorial Sloan Kettering Cancer Center📍 7 sites📅 Started Apr 2021View details ↗
Metarrestin (ML-246) in Subjects With Metastatic Solid Tumors
Multi-Institutional Registry for Malignant Peripheral Nerve Sheath Tumors
👨⚕️ Angela Hirbe, M.D., Ph.D., Washington University School of Medicine📍 13 sites📅 Started Apr 2017View details ↗
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →